Glecaprevir | Annual Sales Report

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,830

2019 Revenue in Millions : 2,893

Growth (%) : -37

Portfolio PDF

Product Web Link

Corporate PDF

02 Brand Name : Mavyret

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 1,710

2020 Revenue in Millions : 1,830

Growth (%) : -7

Portfolio PDF

Product Web Link

Corporate PDF

03 Brand Name : Mavyret

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 1,541

2021 Revenue in Millions : 1,710

Growth (%) : -10

Portfolio PDF

Product Web Link

Corporate PDF

04 Brand Name : Mavyret

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 1,430

2022 Revenue in Millions : 1,541

Growth (%) : -7

Portfolio PDF

Product Web Link

Corporate PDF

05 Brand Name : Mavyret

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Glecaprevir/Pibrentasvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2024 Revenue in Millions : 1,311

2023 Revenue in Millions : 1,430

Growth (%) : -8

Portfolio PDF

Product Web Link

Corporate PDF

06 Brand Name : Mavyret

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Glecaprevir/Pibrentasvir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2018 Revenue in Millions : 3,438

2017 Revenue in Millions : 0

Growth (%) : New Launch

Portfolio PDF

Product Web Link

Corporate PDF

07 Brand Name : Mavyret

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 2,893

2018 Revenue in Millions : 3,438

Growth (%) : -16

Portfolio PDF

Product Web Link